Ultimate Access: GCMI’s Medtech Innovation Book of Knowledge
GCMI is now pleased to offer you a deep-dive, behind-the-scenes look at what we do and how we do it in our comprehensive Book of Knowledge.
Increasing Availability of Lateral Access Spinal Surgery Training: GT Spring ’21 Capstone “Vertebros”
“Our validation work would not have been possible without GCMI’s support and T3 Labs’ facility and equipment. Being ‘radio-opaque’ is a critical design input for this tool. That type of feedback is impossible without a proper operating room environment.”
Attacking the Challenges of Achalasia: GT Capstone’s “G.I. (Mostly) Joes”
“We needed to validate whether or not our device could create the appropriate pressures needed to restore esophageal function in tissue that closely mimics live human tissue… in a safe environment for live tissue where sanitation would not be a concern. The GCMI and T3 Labs team helped prepare the space, tools, and specimen we needed for the validation testing event.”
Georgia Bio Names GCMI, the Saldana Research Group and Georgia Tech 2021 Golden Helix Innovation Award Winner
Georgia Bio, the state’s life science trade association, named GCMI, the Saldana Research Group and Georgia Tech 2021 Golden Helix Innovation Award recipients. The Innovation Award recognizes the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create some unique technology. In early 2020, U.S. frontline healthcare…
Preclinical testing’s role in the medical device design and development phase
In the context of GCMI’s phase-gated product development, the “Design and Development” phase (also called “Phase 2” at GCMI) typically follows a Project Planning phase (called “Phase 1” at GCMI). At the completion of project planning, innovators have determined what work is required to take the technology from prototype to product. The Design and Development…
Under pressure: cadaveric testing yields initial human organ validation for GT Capstone Expo winners’ minimally invasive treatment for cardiac arrest
There are approximately 292,000 cases of in-hospital cardiac arrest every year for which the survival rate is less than 24 percent. Resuscitative efforts and supporting technologies are ineffective, slow, fatiguing, traumatic and expensive. As their Fall 2020 Capstone Project, a group of students from the Georgia Tech Schools of Biomedical, Electrical and Mechanical Engineering…
Critical preclinical considerations to include in the project planning phase of a new medical technology
Where does preclinical work find its way into project planning for new medical technologies? What are the top considerations for preclinical work in this early development stage? GCMI Preclinical Program Director Evan Goldberg shares his insights.
Testing beyond the bench: how GCMI supported GT Capstone’s “Incisionizers” with early stage validation testing for its novel retraction device.
Georgia Tech recently completed its Fall 2020 (virtual) Capstone Design Expo. From the project’s website, “The Capstone Design Expo showcases Georgia Tech’s graduating seniors as they present their innovative projects designed and built during the Capstone Design Course. Students work in teams to solve either an industry problem, develop innovative tools to assist researchers, or…
News: Georgia Tech Names Raghupathy Sivakumar Inaugural Interim Chief Commercialization Officer
Last month, Georgia Tech named Raghupathy “Siva” Sivakumar inaugural Interim Chief Commercialization Officer. From Georgia Tech Research Horizons: “Sivakumar will bring together commercialization and technology transfer activities from across campus with a goal of moving more intellectual property out into the marketplace to help expand Georgia Tech’s impact on the world. Attaining that goal…
How does our design verification and validation phase of medtech development ‘translate’ to preclinical studies?
How does medtech design verification and validation “translate” to preclinical testing? GCMI’s Director of Scientific Affairs explains.